Viatris (NASDAQ:VTRS) said the FDA has declined to approve it and Mapi Pharma's long-acting version of the multiple sclerosis drug glatiramer acetate, or GA, also known as Copaxone. In a statement ...
OK, We are using Crystal Reports on our Citrix farm, and the users almost exclusively export those reports to MAPI and email them out to customers or other company personnel. We're using Outlook 2003 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback